SGEN-Seattle Genetics Stock Research, Ratings, and Analysis

Seattle Genetics (sgen) Stock Research

Last Updated by WikiWealth | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Long Term Rating Stock Ratings Help

HOLD

SWOT Statistics sgen SWOT Analysis

Strengths + Opportunities = 4

Threats + Weaknesses = 2

Add your knowledge to the Seattle Genetics SWOT analysis.

Generic Strategy sgen Generic Strategy

Narrow Scope

Broad Scope

None

Uniqueness

Low Cost

Generic strategies categorize companies by the scope and the strength of their business. Seattle Genetics does not have a definable strategy, therefore, it risks losing out to firms that concentrate on one particular competitive advantage. (read more).

Company Description: Seattle Genetics, Inc., founded in 1997, is a bioTechnology company that develops therapies for the treatment of cancer and autoimmune disease. The company is headquartered in Bothell, Washington. Update

Market Research Update

Industry Sub Sector: .

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

Strategy: Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: